Peripheral Blood Cell Mapping Reveals a Distinct Immune Pattern in Polymyalgia Rheumatica
Single-cell RNA sequencing is giving polymyalgia rheumatica a cellular fingerprint that standard blood tests cannot provide. In this PMR cohort, peripheral blood mononuclear cells from three newly diagnosed, treatment-naive patients were compared with three healthy controls, and the resulting atlas pointed to a skewed immune profile rather than a simple increase or decrease in total inflammation. The most consistent themes were fewer circulating T cells, a larger megakaryocyte/platelet compartment, and myeloid populations carrying inflammatory and interferon-stimulated signatures.
The findings fit the long-standing clinical impression that PMR is not a single-pathway disorder. Its proximal pain, stiffness, elevated inflammatory markers, and overlap with other rheumatologic syndromes suggest a mixed immune process, and the single-cell data bring that idea into sharper focus at the level of individual blood cell states.
One result stood out immediately: circulating T cells were reduced in relative abundance while megakaryocyte/platelet signals were expanded. In a disease dominated by musculoskeletal symptoms, that shift may look indirect at first glance, yet platelets are increasingly recognized as active participants in inflammatory trafficking and vascular immune signaling. A larger platelet-associated compartment can reflect systemic immune activation rather than a purely hemostatic event.
T Cell Subsets Showed Loss of Classical Adaptive Balance
At the T-cell level, PMR was associated with an increased proportion of pro-inflammatory KIR+NK-like T cells. At the same time, CD4+ central memory T cells, effector memory T cells, and Th1 cells were reduced in relative abundance. The pattern suggests a reorganization of adaptive immunity rather than a blanket suppression. Memory and helper populations normally help coordinate antigen-specific responses; their contraction may indicate that these cells are being redistributed, exhausted, or functionally displaced by a more innate-like inflammatory program.
The reduction in Th1 cells is particularly relevant because Th1 biology is tightly linked to interferon signaling and macrophage activation. In PMR, that axis appears to be re-routed into a different cellular architecture, with immune surveillance shifting away from conventional helper T-cell dominance and toward cytotoxic and interferon-responsive states.
NK Cells and Interferon Signatures Dominated the Innate Arm
Natural killer cell subsets were disproportionately represented in PMR, and the CD56dimCD16hi-ISG subset was found only in the PMR cases. That detail matters because interferon-stimulated genes are a direct readout of an immune system under antiviral-like or cytokine-driven pressure. The exclusive presence of that subset in the disease samples points to a discrete activation program rather than a minor fluctuation in baseline NK biology.
Monocyte findings were even more striking. Multiple monocyte subsets annotated for elevated inflammatory and interferon-stimulated gene signatures, including CD14_Monocyte-ISG and CD16_Monocyte-IFITM1, were uniformly expanded in the PMR cohort. These cells sit at the interface of innate sensing and tissue inflammation. When they carry interferon signatures, they are not simply present in larger numbers; they are primed to amplify cytokine cascades, antigen handling, and downstream immune recruitment.
Functional enrichment analysis aligned with that interpretation. Co-stimulation, cytotoxicity, antigen processing and presentation, and inflammation promotion were all enhanced across several immune populations. Key inflammatory pathways were broadly activated, including the interferon-γ signaling pathway, interleukin-1β production, and NK cell-mediated cytotoxicity. In practical terms, the blood compartment looked immunologically louder, more alert, and more predisposed to inflammatory escalation.
B Cells Were Numerically Similar but Immunologically Reorganized
B cells did not show a statistically meaningful shift in their overall proportional distribution, yet the unswitched memory B-cell compartment was absent in the PMR samples. That absence suggests that stable numbers can mask meaningful qualitative changes. A preserved total B-cell fraction does not guarantee preserved function, especially when one memory compartment disappears and the remaining subsets may be operating under a different activation state.
The study did not identify a global collapse of B-cell biology. Instead, it pointed to selective remodeling, with one memory arm missing from the peripheral blood landscape. For a syndrome still debated as auto-inflammatory, autoimmune, or mixed, that kind of selective loss is more informative than crude cell counts.
Cell-to-Cell Signaling Shifted Toward TGF-β and CD48 Pathways
Cell communication analysis added another layer. PMR samples showed more interactions overall, but the communication strength was slightly weaker. Increased signaling was observed in the TGF-β and CD48 pathways. This combination hints at a network that is busier but not necessarily more efficient, with signaling channels proliferating while the intensity of each interaction becomes diluted.
TGF-β signaling often sits at the boundary between immune activation and immune restraint. In an inflammatory disease, increased TGF-β pathway communication may reflect a compensatory attempt to limit immune injury, or a remodeling signal embedded within chronic inflammation. CD48-mediated communication points in a different direction, toward immune-cell contact and activation pathways that can support cytotoxic and innate-adaptive crosstalk.
What This Means for PMR Biology and Future Biomarker Work
The study provides a preliminary single-cell view of PMR that favors a mixed immune mechanism. The blood compartment contained fewer classical T cells, more NK-like cytotoxic states, expanded interferon-primed monocytes, and altered signaling in inflammatory pathways tied to antigen presentation and cytokine amplification. Those findings are consistent with a disorder driven by intertwined innate and adaptive immune programs rather than a single dominant cell type.
The work also points toward practical biomarker possibilities. If larger cohorts confirm these signatures, circulating interferon-stimulated monocytes, NK cell subsets, and specific T-cell remodeling patterns could help support diagnosis or stratify disease activity. The data may also help explain why glucocorticoids remain effective across many PMR patients: broad immunosuppression can dampen multiple activated pathways at once, which is exactly the kind of biology this single-cell map suggests.
The limitations are immediate and unavoidable. Only three untreated PMR patients were studied, and the comparison relied on three control datasets downloaded from a public platform. Even with careful integration and pseudobulk analysis, that size is too small for firm statistical claims about population-level biology. The study is best read as an exploratory atlas, not a validated diagnostic model.
Still, the cellular pattern is coherent. PMR blood is not simply inflamed; it is reorganized, with interferon-linked monocytes, NK-cell activation, and selective loss of conventional T-cell and B-cell states. The next question is whether these signatures persist across larger cohorts, track with disease activity, and remain visible after treatment alters the immune set point.